Form 4: Thermo Fisher Officer Sells Shares for Tax Purposes

Joseph R. Holmes, VP & Chief Accounting Officer at Thermo Fisher Scientific, reported the disposition of 116.626 shares of common stock for tax purposes.

Summary

• Joseph R. Holmes, the Vice President and Chief Accounting Officer of Thermo Fisher Scientific Inc. (TMO), reported transactions in the company's common stock.
• The transactions involved the disposition of a total of 116.626 shares of common stock on February 28, 2026.
• These dispositions were made at a price of $521.11 per share.
• The transaction code 'F' indicates that these shares were disposed of to satisfy tax withholding obligations related to the vesting of equity awards.
• Following these reported transactions, Joseph R. Holmes beneficially owns 2,966.3555 shares of Thermo Fisher Scientific common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, pre-planned disposition of shares for tax withholding purposes, which is a common occurrence for executives receiving equity compensation.

Positives

• The transaction is a routine disposition for tax purposes, indicating the vesting of equity awards for the officer, which is a standard component of executive compensation.

Negatives

• The disposition of shares by an insider, even for tax purposes, reduces their direct ownership stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider dispositions for tax purposes are common and generally not indicative of a change in company fundamentals or management's long-term view, especially when executed under a Rule 10b5-1 plan, which allows insiders to set up pre-scheduled trades to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, pre-planned transaction for tax purposes and does not signal a change in company strategy or performance.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by an officer for tax withholding purposes, executed under a Rule 10b5-1 plan. Such transactions are generally not indicative of a change in the company's fundamental outlook or the insider's confidence, and therefore do not typically warrant a change in investment recommendation.

Keywords

Thermo Fisher Scientific, TMO, Insider Transaction, Form 4, Stock Sale, Joseph R. Holmes, Chief Accounting Officer, Equity Disposition, 10b5-1 Plan